Comparable activity with oral topotecan/cisplatin (TC) and IV etoposide/cisplatin (PE) as treatment for chemotherapy-naïve patients (pts) with extensive disease small cell lung cancer (ED-SCLC): Final results of a randomized phase III trial (389)
2005 ◽
Vol 23
(16_suppl)
◽
pp. 7003-7003
◽
Keyword(s):
2004 ◽
Vol 22
(14_suppl)
◽
pp. 7046-7046
◽
Keyword(s):
2004 ◽
Vol 22
(14_suppl)
◽
pp. 7046-7046
◽
Keyword(s):
Keyword(s):
Keyword(s):
2008 ◽
Vol 26
(15_suppl)
◽
pp. 7513-7513
◽
Keyword(s):
2007 ◽
Vol 2
(8)
◽
pp. S390
◽
Keyword(s):
2007 ◽
Vol 97
(2)
◽
pp. 162-169
◽
Keyword(s):
2005 ◽
Vol 23
(16_suppl)
◽
pp. LBA7010-LBA7010
◽
Keyword(s):
2009 ◽
Vol 27
(15_suppl)
◽
pp. 8029-8029
Keyword(s):